| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 43 |
| 1 | ADALIMUMAB | 32 |
| 2 | METHOTREXATE SODIUM | 32 |
| 3 | METHOTREXATE | 31 |
| 4 | FLUDARABINE PHOSPHATE | 25 |
| 5 | CYCLOPHOSPHAMIDE | 21 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 21 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 21 |
| 8 | MYCOPHENOLATE MOFETIL | 21 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 13 | 0.0903 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 17 | 0.0688 |
| 2 | CHLORPROMAZINE HYDROCHLORIDE | 11 | 0.0115 |
| 3 | HYDRALAZINE HYDROCHLORIDE | 10 | 0.0037 |
| 4 | METHYLDOPA | 17 | 0.0034 |
| 5 | PRAZIQUANTEL | 1 | 0.0033 |
| 6 | ETHOSUXIMIDE | 8 | 0.0032 |
| 7 | CASPOFUNGIN ACETATE | 4 | 0.0025 |
| 8 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| 9 | MINOCYCLINE HYDROCHLORIDE | 9 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 48 |
| 1 | Corticosteroid [EPC] | 35 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 |
| 3 | Alkylating Drug [EPC] | 33 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 31 |
| 5 | Anti-epileptic Agent [EPC] | 28 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 7 | Proton Pump Inhibitor [EPC] | 26 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 9 | Azole Antifungal [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bismuth [EPC] | 7 | 0.0013 |
| 1 | Allylamine Antifungal [EPC] | 6 | 0.0008 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 8 | 0.0004 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 | 0.0004 |
| 5 | Anthelmintic [EPC] | 1 | 0.0003 |
| 6 | Penem Antibacterial [EPC] | 10 | 0.0003 |
| 7 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 12 | 0.0002 |
| 9 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |